Rubius Therapeutics (RUBY) Reports Q3 Loss of $0.59

Go back to Rubius Therapeutics (RUBY) Reports Q3 Loss of $0.59
(NASDAQ: RUBY) Delayed: 0.08 --0 (-0%)
Previous Close $0.08    52 Week High
Open $1.17    52 Week Low
Day High $0.08    P/E N/A 
Day Low $0.08    EPS
Volume 518,325